Prospective Observational Epidemiologic Study of Maraviroc's Safety
Status:
Completed
Trial end date:
2019-02-14
Target enrollment:
Participant gender:
Summary
The study will assess if use of maraviroc along with an optimized background regimen of
antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen
of antiretroviral drugs.